AlloVir Long Term Debt Current 2011-2026 | ALVR

Annual Long Term Debt Current AlloVir

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	10.8 M	7.16 M	6.59 M	3.23 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
10.8 M	3.23 M	6.94 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	3.63 M	-	2.43 %	$ 254 M	Germany
Aptorum Group Limited APM	433 K	$ 0.82	-3.48 %	$ 4.47 M	China
Rigel Pharmaceuticals RIGL	614 K	$ 33.23	-4.03 %	$ 584 M	USA
I-Mab IMAB	8.06 M	-	-	$ 866 M	China
Acer Therapeutics ACER	104 K	-	2.71 %	$ 14 M	USA
Ampio Pharmaceuticals AMPE	274 K	-	-11.43 %	$ 502 K	USA
Apellis Pharmaceuticals APLS	7.09 M	$ 20.15	-2.68 %	$ 2.54 B	USA
AbCellera Biologics ABCL	5.82 M	$ 3.72	-2.75 %	$ 1.11 B	Canada
Athersys ATHX	1.01 M	-	3.77 %	$ 22.4 M	USA
AVEO Pharmaceuticals AVEO	11 K	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	434 K	$ 163.7	-1.61 %	$ 8.14 B	USA
BridgeBio Pharma BBIO	6.19 M	$ 64.66	-1.37 %	$ 12.4 B	USA
Brainstorm Cell Therapeutics BCLI	549 K	-	-2.5 %	$ 5.88 M	USA
Adverum Biotechnologies ADVM	5.67 M	-	-	$ 86.2 M	USA
CymaBay Therapeutics CBAY	7 K	-	-	$ 3.45 B	USA
Avid Bioservices CDMO	1.35 M	-	-	$ 789 M	USA
Certara CERT	3.92 M	$ 7.16	1.49 %	$ 1.15 B	USA
ARCA biopharma ABIO	213 K	-	1052.0 %	$ 415 M	USA
Caladrius Biosciences CLBS	137 K	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	756 K	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	1.59 M	-	-24.86 %	$ 820 K	USA
Capricor Therapeutics CAPR	749 K	$ 25.91	-3.56 %	$ 694 M	USA
Catalyst Pharmaceuticals CPRX	437 K	$ 24.0	0.5 %	$ 2.93 B	USA
Acasti Pharma ACST	75 K	-	4.01 %	$ 150 M	Canada
Codexis CDXS	2.83 M	$ 0.99	-3.28 %	$ 72.7 M	USA
Corvus Pharmaceuticals CRVS	1.37 M	$ 17.75	-0.79 %	$ 852 M	USA
CTI BioPharma Corp. CTIC	781 K	-	-	$ 1.2 B	USA
Deciphera Pharmaceuticals DCPH	3.5 M	-	-	$ 2.18 B	USA
CureVac N.V. CVAC	3.47 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	271 K	-	5.93 %	$ 314 M	Canada
Denali Therapeutics DNLI	8.31 M	$ 20.02	-4.67 %	$ 3.29 B	USA
AgeX Therapeutics AGE	428 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	625 K	-	-	$ 1.01 B	USA
Eton Pharmaceuticals ETON	5.38 M	$ 17.54	-3.36 %	$ 450 M	USA
Entasis Therapeutics Holdings ETTX	704 K	-	-	$ 105 M	USA
Evofem Biosciences EVFM	97 K	-	7.55 %	$ 38.1 M	USA